A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended
NCT00922090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1494
Last updated 2010-03-12
Summary
The primary objective of this NIS is to assess the clinical benefit subjects derive from taking seroquel XR, using the CGI-CB. The secondary objective is to assess the effectiveness,safety and tolerability of seroquel XR tablets.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
JoonWoo Bahn, MD, PhD · AstraZeneca Korea
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Seroquel XR in Adults With Schizophrenia
NCT00852631 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
NCT00689325 ·Status: COMPLETED
-
Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia
NCT00934726 ·Status: COMPLETED
-
Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR
NCT00750087 ·Status: COMPLETED
-
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy
NCT01128114 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
NCT01256177 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Extended Release Depression Symptoms
NCT00640562 ·Status: COMPLETED ·Phase: PHASE3
-
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
NCT00206115 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia
NCT01213836 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
NCT00981123 ·Status: COMPLETED
-
Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
NCT00085891 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia
NCT00090324 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
NCT01214135 ·Status: COMPLETED
-
Fast Titration in the Treatment of Schizophrenia, Taiwan
NCT00304473 ·Status: COMPLETED ·Phase: PHASE3
-
Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia
NCT00206128 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Efficacy in Bipolar Depression Study
NCT00523601 ·Status: COMPLETED
-
Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic
NCT00428350 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia
NCT00690365 ·Status: COMPLETED
-
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
NCT00600756 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
NCT01971203 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Seroquel vs. Risperidone in Schizophrenia
NCT00034905 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study
NCT01254721 ·Status: TERMINATED ·Phase: PHASE4
-
Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
NCT00234377 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
NCT00422214 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
NCT00329264 ·Status: COMPLETED ·Phase: PHASE3